Position in AMRN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,826,560
+$2,601,042 QoQ
Shares Held
177,325
+1037.0% QoQ
Ownership
0.839%
of shares outstanding
% of Portfolio
2.27%
of 13F equity value
Holder Rank
#6
of 80 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRN Over Time
Shares Held
Position Value (USD)
Derivatives in AMRN
reported options exposure · as of Sep 30, 2025CallValue
$604,192
CallShares
36,886
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brooklands Fund Management Ltd holds $4,525,793 across 2 Drug Manufacturers - General names. AMRN ranks #1 (62.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRN |
Amarin Corp Plc\Uk
This page
|
177,325 | $2,826,560 | |
| 2 | NVO |
Novo Nordisk A S
|
35,445 | $1,699,233 |
All Filings in AMRN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,826,560 | 177,325 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $225,518 | 15,596 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $41,796 | 2,994 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $604,192 | 36,886 | Call | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||